BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Leggett & Platt
LEG
$1.34B
| $568M | 0.02% |
10,954,333
+10,365
| +0.1% | +$539K |
|
927
Concentrix
CNXC
$1.5B
| $567M | 0.02% |
3,528,911
-82,340
| -2% | -$12.7M |
|
928
Essential Properties Realty Trust
EPRT
$6.77B
| $567M | 0.02% |
20,958,823
+3,498,099
| +20% | +$90.9M |
|
929
Pacific Biosciences
PACB
$435M
| $566M | 0.02% |
16,189,432
-303,683
| -2% | -$8.83M |
|
930
Sabra Healthcare REIT
SBRA
$5.34B
| $566M | 0.02% |
31,079,213
+637,071
| +2% | +$11.3M |
|
931
Enterprise Products Partners
EPD
$82.3B
| $565M | 0.02% |
23,395,467
+4,689,634
| +25% | +$111M |
|
932
New Jersey Resources
NJR
$5.84B
| $564M | 0.02% |
14,259,250
-300,032
| -2% | -$12.7M |
|
933
MDU Resources
MDU
$4.17B
| $564M | 0.02% |
47,303,494
-404,403
| -0.8% | -$5.07M |
|
934
Unity
U
$13.8B
| $563M | 0.02% |
5,122,563
+3,576,246
| +231% | +$351M |
|
935
SLM Corp
SLM
$4.89B
| $560M | 0.02% |
26,744,384
-3,593,641
| -12% | -$70.8M |
|
936
Onto Innovation
ONTO
$12.9B
| $559M | 0.02% |
7,649,292
-172,680
| -2% | -$11.9M |
|
937
Neogen
NEOG
$2.63B
| $559M | 0.02% |
12,134,282
-394,076
| -3% | -$18.2M |
|
938
SPS Commerce
SPSC
$2.64B
| $558M | 0.02% |
5,583,430
-142,774
| -2% | -$14.1M |
|
939
Acuity Brands
AYI
$9.83B
| $557M | 0.02% |
2,978,883
-348,730
| -10% | -$63.4M |
|
940
Varonis Systems
VRNS
$4.59B
| $556M | 0.02% |
9,646,884
+231,218
| +2% | +$12M |
|
941
Selective Insurance
SIGI
$5.65B
| $555M | 0.02% |
6,842,422
-229,845
| -3% | -$17.6M |
|
942
Unifirst Corp
UNF
$5.3B
| $554M | 0.02% |
2,362,718
-47,534
| -2% | -$10.7M |
|
|
XLRN
943
DELISTED
Acceleron Pharma
XLRN
| $553M | 0.02% |
4,403,225
-225,753
| -5% | -$28.5M |
|
944
TAL Education Group
TAL
$6.93B
| $552M | 0.02% |
21,882,936
+2,230,117
| +11% | +$99.6M |
|
945
Denali Therapeutics
DNLI
$3.65B
| $552M | 0.02% |
7,036,041
+471,589
| +7% | +$29.2M |
|
946
Park Hotels & Resorts
PK
$3.03B
| $551M | 0.02% |
26,747,926
-841,822
| -3% | -$18M |
|
947
Cullen/Frost Bankers
CFR
$10.3B
| $551M | 0.02% |
4,918,329
-160,330
| -3% | -$18.7M |
|
948
LCI Industries
LCII
$2.49B
| $551M | 0.02% |
4,189,449
+40,138
| +1% | +$5.63M |
|
949
Dick's Sporting Goods
DKS
$17.5B
| $546M | 0.02% |
5,450,813
-988,851
| -15% | -$88.6M |
|
950
IPG Photonics
IPGP
$3.61B
| $545M | 0.02% |
2,585,946
-90,005
| -3% | -$18.9M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.